Company Filing History:
Years Active: 2016-2024
Title: Inbal Goldshtein: Innovator in Cancer Risk Evaluation
Introduction
Inbal Goldshtein is a prominent inventor based in Ramat-Hasharon, Israel. She has made significant contributions to the field of medical research, particularly in evaluating cancer risks through innovative methods. With a total of five patents to her name, Goldshtein is recognized for her groundbreaking work in utilizing blood test results to assess the risk of various cancers.
Latest Patents
Goldshtein's latest patents include methods and systems for evaluating the risk of lung cancer and gastrointestinal cancer. The lung cancer risk evaluation method involves generating a set of features from current blood test results collected from a target individual. This method utilizes classifiers based on historical blood test results from a diverse group of sampled individuals. The evaluation process employs a processor to classify the features and determine the lung cancer risk for the target individual. Similarly, her gastrointestinal cancer risk evaluation method follows a comparable approach, focusing on current blood test results and historical data to assess the risk effectively.
Career Highlights
Inbal Goldshtein is currently associated with Medical Research Ltd., where she continues to advance her research and innovations. Her work has garnered attention for its potential to improve early detection and risk assessment of cancers, which can lead to better patient outcomes.
Collaborations
Goldshtein collaborates with notable colleagues, including Nir Kalkstein and Yaron Kinar, who contribute to her research endeavors. Their combined expertise enhances the development of innovative solutions in the medical field.
Conclusion
Inbal Goldshtein stands out as a leading inventor in the realm of cancer risk evaluation. Her innovative methods and dedication to medical research have the potential to transform how cancer risks are assessed and managed.